Skip to content

The Residual effect of Homoeopathic medicine for snoring in Adenoid Hypertrophy.

Carry over effect of Individualized Homoeopathic medicine for the symptom snoring in Adenoid Hypertrophy-A Randomized Cross over study. - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/06/089339
Enrollment
60
Registered
2025-06-23
Start date
Unknown
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J352- Hypertrophy of adenoids

Interventions

Intervention1: Individualised Homoeopathic Medicines: Patients will be recruited from the Outpatient Department (OPD), Inpatient Department (IPD), peripheral centers, and camps. The study duration is

Sponsors

Dr SUDHA R
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age between 2-13years 2. Children presenting with snoring having a FPRS Score (1-3) 3. Children diagnosed with Adenoid Hypertrophy on Xray Nasopharynx.

Exclusion criteria

Exclusion criteria: 1.Children presenting with grade 4 Adenoid hypertrophy with A/N more than 75% 2.Patients with underlying immune deficiencies, neoplasia 3. Children with cranio facial deformities. 4. Children with bleeding disorders.

Design outcomes

Primary

MeasureTime frame
Carry over effect of Individualized homoeopathic medicine in Adenoid hypertrophy for the symptom snoring is assessed with Four Point Clinical Rating Score.Timepoint: Four Point Clinical Rating Score will be calculated at baseline,3rd and 6th month

Secondary

MeasureTime frame
Reduction in Adenoid Nasopharyngeal ratio after the administration of individualized homoeopathic medicine in AdenoidHypertrophy. Improvement in airway obstruction by using Modified Mallampati Score. symptomatic improvement after homoeopathic intervention by using SRBD PSQ Score (Sleep Related Breathing Disorder for Paediatric Sleep Questionnaire)Timepoint: Adenoid Nasopharyngeal ratio At baseline & 6th month Modified Mallampati score From baseline to 6th month. SRBD PSQ Score From Baseline to 6th month.

Countries

India

Contacts

Public ContactDr Vinitha E R

National Homoeopathic Research Institute In Mental Health,Kottayam

vinitha_sajeev@yahoo.co.in9567847444

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026